Skip to main content
. 2022 Dec 20;159(6):527–535. doi: 10.1007/s00418-022-02163-4

Table 2.

Clinical details of the patients with gestational diabetes mellitus and of the normal control group stratified by fetal sex

Characteristics GDM group Healthy control group p-value
Male (n = 20) Female (n = 20) Male (n = 20) Female (n = 20)
Maternal age (years) 31.5 ± 4.1 33.2 ± 5.33 30.3 ± 6.11 32.0 ± 6.13 ns
Maternal BMI (pre-pregnancy) (kg/m2) 29.4 ± 8.03 27.0 ± 4.73 21.9 ± 3.97 25.0 ± 7.90  < 0.001*
Gestational age at delivery (weeks) 39.7 ± 1.30 39.8 ± 1.40 39.8 ± 1.54 39.8 ± 1.16 ns
Median gravidity (IQR) 2 (1.75) 2 (2) 2 (1) 2 (1) ns
Median parity (IQR) 2 (1.75) 1 (1) 1 (1) 2 (1) ns
Mean HbA1c (%) 5.9 ± 0.4 5.7 ± 0.3 n. a n. a ns
With labour (%) 75 95 85 85 ns
Birth weight (g) 3662 ± 562 3636 ± 661 3340 ± 568 3294 ± 440  < 0.05*
Umbilical artery pH 7.30 ± 0.07 7.30 ± 0.10 7.30 ± 0.10 7.30 ± 0.08 ns
Median 5 min APGAR (minimum; maximum) 10 (9; 10) 10 (8; 10) 10 (8; 10) 10 (8; 10) ns

If not indicated otherwise, data are presented as the mean ± SD or as the median with minimum and maximum in parentheses, as appropriate

*Statistically significant difference between groups: GDM group vs. control group including fetal sex, using the Kruskal–Wallis’s test to compare clinical outcome data of the four groups